S1PR5 anticorps (N-Term)
Aperçu rapide pour S1PR5 anticorps (N-Term) (ABIN630339)
Antigène
Voir toutes S1PR5 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- EDG8 antibody was raised against the N terminal of EDG8
-
Purification
- Purified
-
Immunogène
- EDG8 antibody was raised using the N terminal of EDG8 corresponding to a region with amino acids MESGLLRPAPVSEVIVLHYNYTGKLRGARYQPGAGLRADAVVCLAVCAFI
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EDG8 Blocking Peptide, (ABIN5613303), is also available for use as a blocking control in assays to test for specificity of this EDG8 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EDG8 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- S1PR5 (Sphingosine-1-Phosphate Receptor 5 (S1PR5))
-
Autre désignation
- EDG8
-
Sujet
- EDG8 is a receptor for the lysosphingolipid sphingosine 1-phosphate (S1P). S1P is a bioactive lysophospholipid that elicits diverse physiological effect on most types of cells and tissues. It Is coupled to both the G(i/0)alpha and G(12) subclass of heteromeric G-proteins (By similarity). It may play a regulatory role in the transformation of radial glial cells into astrocytes and may affect proliferative activity of these cells.
-
Poids moléculaire
- 16 kDa (MW of target protein)
Antigène
-